Clinical characterization of suprachoroidal injection procedure utilizing a microinjector across three retinal disorders

Chen Rei Wan, Barry Kapik, Charles C. Wykoff, Christopher R. Henry, Mark R. Barakat, Milan Shah, Rafael V. Andino, Thomas A. Ciulla

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Purpose: This study assessed physician-investigator experience with suprachoroidal (SC) injections, an investigational therapeutic administration technique using a 900 or 1100 μm microneedle to inject drugs into the SC space. Methods: Datasets from six clinical trials across three diseases (noninfectious uveitis; diabetic macula edema, and retinal vein occlusion) were assessed. In addition to a user survey, retrospective correlations were performed between procedural variables (needle length), and demographics, and ocular characteristics. Results: In the user survey, 84% (31/37) of physician-investigators did not perceive the SC injections to be meaningfully more challenging than other ocular injections. For the correlation analysis, the 900 μm needle was used for 71% (412/581) of baseline injections, and switching to the longer needle occured in the remaining 29% of baseline injections. No statistical correlations were found between needle lengths and age, race, disorder, refraction, visual acuity, intraocular pressure, retinal central subfield thickness, or lens status. Patient gender and needle length were statistically associated, with 76% (210/275) versus 66% (202/306) of injections administered with 900 μm needles for female and male gender, respectively. Injection quadrant correlated to needle length with 78% (214/275) of superotemporal quadrant injections administered with 900 μm needles, compared with 65% (73/113) of inferotemporal quadrant injections. Conclusions: Both the user survey and the correlation analysis demonstrated that SC injection is well accepted by physician-investigators, and the two needle lengths accommodate a wide range of anatomic and demographic variables. Translational Relevance: These results, along with the presented ex-vivo endoscopic imaging, suggest that SC injection could be readily adopted in clinical practice for targeted compartmentalized delivery of ocular therapeutics.

Original languageEnglish (US)
Article number27
Pages (from-to)1-10
Number of pages10
JournalTranslational Vision Science and Technology
Volume9
Issue number11
DOIs
StatePublished - 2020

Keywords

  • Microinjector
  • Microneedle
  • SCS
  • Suprachoroidal

ASJC Scopus subject areas

  • Biomedical Engineering
  • Ophthalmology

Fingerprint Dive into the research topics of 'Clinical characterization of suprachoroidal injection procedure utilizing a microinjector across three retinal disorders'. Together they form a unique fingerprint.

Cite this